NasdaqGS:IARTMedical Equipment
A Look At Integra LifeSciences (IART) Valuation After Earnings Beat And CEO Stuart Essig’s Return
Earnings beat and leadership shift put Integra LifeSciences Holdings (IART) in focus
Integra LifeSciences Holdings (IART) is back on investors’ radar after first quarter results topped Wall Street expectations. This development comes alongside CEO Stuart Essig’s return, with management reaffirming full year revenue guidance and raising adjusted EPS guidance.
See our latest analysis for Integra LifeSciences Holdings.
The stock has gained 26.57% on a 30 day share price basis and 24.56% over 90...